Beijing Kawin Technology Share-holding Co Ltd
SSE:688687

Watchlist Manager
Beijing Kawin Technology Share-holding Co Ltd Logo
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Watchlist
Price: 25.64 CNY -0.39% Market Closed
Market Cap: 4.4B CNY
Section:
 

Relative Value

The Relative Value of one Beijing Kawin Technology Share-holding Co Ltd stock under the Base Case scenario is 38.29 CNY. Compared to the current market price of 25.64 CNY, Beijing Kawin Technology Share-holding Co Ltd is Undervalued by 33%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
38.29 CNY
Undervaluation 33%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.7
P/S
P/S
Price to Sales
3.7
vs History
25
vs Industry
72
Median 3Y
3.6
Median 5Y
3
Industry
7.9
Forward
3.4
More Details
31.3
P/E
P/E
Price to Earnings
31.3
vs History
50
vs Industry
6
Median 3Y
37.1
Median 5Y
31.2
Industry
24
Forward
25.7
More Details
39.1
P/OCF
P/OCF
Price to OCF
39.1
vs History
16
vs Industry
6
Median 3Y
34.6
Median 5Y
28.8
Industry
21.6
More Details
16.9
P/FCFE
P/FCFE
Price to FCFE
16.9
vs History
55
vs Industry
5
Median 3Y
33.2
Median 5Y
21.9
Industry
23.7
More Details
2.4
P/B
P/B
Price to Book Value
2.4
vs History
51
vs Industry
39
Median 3Y
2.5
Median 5Y
2.4
Industry
3.4
More Details
2.8
EV/S
EV/S
Enterprise Value to Sales
2.8
vs History
23
vs Industry
65
Median 3Y
2.7
Median 5Y
2.2
Industry
8.3
Forward
2.6
More Details
3.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.5
vs History
21
vs Industry
67
Median 3Y
3.2
Median 5Y
2.7
Industry
10.3
More Details
21.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
21.7
vs History
50
vs Industry
8
Median 3Y
23.7
Median 5Y
21.7
Industry
6.7
Forward
12.9
More Details
21.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
21.7
vs History
50
vs Industry
8
Median 3Y
23.7
Median 5Y
21.7
Industry
7.2
Forward
-239
More Details
29.8
EV/OCF
EV/OCF
Enterprise Value to OCF
29.8
vs History
19
vs Industry
7
Median 3Y
26.4
Median 5Y
21.5
Industry
8.2
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
3
Median 3Y
-35.8
Median 5Y
-43.2
Industry
6.7
More Details
2.8
EV/IC
EV/IC
Enterprise Value to IC
2.8
vs History
75
vs Industry
40
Median 3Y
3.6
Median 5Y
3.5
Industry
5.7
More Details

Multiples Across Competitors

Competitors Multiples
Beijing Kawin Technology Share-holding Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
4.3B CNY 3.7 31.3 21.7 21.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 067 817 -161 919.3 -196 621.7 -194 378
US
Abbvie Inc
NYSE:ABBV
394.1B USD 6.6 167.8 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
170.6B USD 4.7 24.4 17.7 17.7
US
Gilead Sciences Inc
NASDAQ:GILD
148.3B USD 5.1 18.3 12.3 12.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
111B USD 9.5 30.2 22.1 23.1
US
Epizyme Inc
F:EPE
94.1B EUR 2 067.9 -527.7 -574.6 -559.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
73.7B USD 5.2 16.1 15.2 17.3
AU
CSL Ltd
ASX:CSL
88.5B AUD 3.8 19.5 13.1 16.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
55.1B USD 17.2 1 265.5 166.5 201.9
NL
argenx SE
XBRU:ARGX
47B EUR 15.2 35.7 61.8 63.5
P/E Multiple
Earnings Growth PEG
CN
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Average P/E: 178.8
31.3
19%
1.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 919.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
167.8
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.4
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.3
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.2
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.1
9%
1.8
AU
CSL Ltd
ASX:CSL
19.5
11%
1.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 265.5
N/A N/A
NL
argenx SE
XBRU:ARGX
35.7
40%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Average EV/EBITDA: 38.5
21.7
26%
0.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 621.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.7
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.3
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.1
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -574.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.2
11%
1.4
AU
CSL Ltd
ASX:CSL
13.1
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
166.5
N/A N/A
NL
argenx SE
XBRU:ARGX
61.8
807%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Average EV/EBIT: 44.1
21.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 378 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.7
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.3
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.1
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
13%
1.3
AU
CSL Ltd
ASX:CSL
16.4
11%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
201.9
N/A N/A
NL
argenx SE
XBRU:ARGX
63.5
N/A N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 301,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.